Table 2.
Body Weight (g) |
Femoral aBMD (g/cm2) |
Femoral aBMC (g) |
Lean Mass (g) |
Fat Mass (g) |
Number of Adipocytes (N.Ad) |
Adipocyte Volume (Ad.V) |
|
---|---|---|---|---|---|---|---|
CON-LFD group | |||||||
Body Weight (g) | 1 | ||||||
Femoral aBMD (g/cm2) | 0.51 | 1 | |||||
Femoral aBMC (g) | 0.31 | 0.76* | 1 | ||||
Lean Mass (g) | 0.57 | 0.58 | 0.38 | 1 | |||
Fat Mass (g) | 0.66* | 0.09 | 0.005 | −0.22 | 1 | ||
Number of adipocytes (N.Ad) | −0.33 | 0.35 | 0.0 | −0.87 | 0.21 | 1 | |
Adipocyte Volume (Ad.V) | 0.72 | 0.51 | 0.43 | 0.12 | 0.72 | −0.10 | 1 |
STZ-LFD group | |||||||
Body Weight (g) | 1 | ||||||
Femoral aBMD (g/cm2) | 0.76* | 1 | |||||
Femoral BMC (g) | 0.66 | 0.87* | 1 | ||||
Lean Mass (g) | 0.94* | 0.82* | 0.73* | 1 | |||
Fat Mass (g) | 0.17 | 0.23 | −0.06 | 0.26 | 1 | ||
Number of adipocyte (N.Ad) | 0.21 | −0.50 | −0.29 | 0.22 | −0.19 | 1 | |
Adipocyte Volume (Ad.V) | 0.003 | −0.73 | −0.57 | −0.06 | 0.01 | 0.94* | 1 |
CON-HFD group | |||||||
Body Weight (g) | 1 | ||||||
Femoral aBMD (g/cm2) | −0.10 | 1 | |||||
Femoral BMC (g) | −0.26 | 0.86 | 1 | ||||
Lean Mass (g) | 0.11 | 0.80* | 0.76* | 1 | |||
Fat Mass (g) | 0.93 | −0.39 | −0.56 | −0.25 | 1 | ||
Number of adipocyte (N.Ad) | −0.37 | 0.68 | 0.69 | 0.86 | −0.49 | 1 | |
Adipocyte Volume (Ad.V) | −0.57 | 0.78 | 0.85 | 0.87 | −0.67 | 0.97 | 1 |
STZ-HFD group | |||||||
Body Weight (g) | 1 | ||||||
Femoral aBMD (g/cm2) | 0.90* | 1 | |||||
Femoral BMC (g) | 0.81 | 0.84 | 1 | ||||
Lean Mass (g) | 0.97 | 0.89* | 0.75* | 1 | |||
Fat Mass (g) | 0.43 | 0.27 | 0.60* | 0.28 | 1 | ||
Number of adipocyte (N.Ad) | 0.07 | −0.02 | −0.08 | −0.02 | 0.62 | 1 | |
Adipocyte Volume (Ad.V) | −0.10 | −0.43 | −0.38 | −0.19 | 0.83 | 0.83 | 1 |
p-value < 0.05.